Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1

Conditions

Psoriasis 3Prostatic Neoplasms 1Lymphoma, Follicular 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
deucravacitinib × Clear all
NCT07335796 2026-03-13

A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT07256015 2025-12-01

Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy

Bristol-Myers Squibb

Recruiting
200 enrolled
Lymphoid

Lymphoma, Follicular, Psoriasis

NCT06952465 2025-05-01

A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis

Bristol-Myers Squibb

Active not recruiting
2,000 enrolled

Psoriasis

NCT06281106 2025-04-02

TYPP

Centre Hospitalier Universitaire Vaudois

Phase 2/3 Terminated
2 enrolled

Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡